^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SYH2043

    i
    Other names: SYH2043
    Associations

    News

    Trials
    Company:
    CSPC Pharma
    Drug class:
    CDK4 inhibitor, CDK6 inhibitor, CDK2 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over1year
    Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors (clinicaltrials.gov)
    P1, N=367, Not yet recruiting, CSPC Ouyi Pharmaceutical Co., Ltd.
    New P1 trial • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
    |
    SYH2043